SARAH LE: Open Payments
NPI 1720747033 · KINGWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$817 in 35 payments from 18 companies in 2025. Trend: 2023 $676 · 2024 $456 · 2025 $817
Food & beverage: $817
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $143 |
| Novo Nordisk Inc | 5 | $102 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Exact Sciences Corporation | 3 | $54 |
| ABBVIE INC. | 2 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $49 |
| Lilly USA, LLC | 2 | $48 |
| Inspire Medical Systems, Inc. | 1 | $38 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
Products named: XIFAXAN, TRELEGY ELLIPTA, Cologuard Collection Kit, Ozempic, VRAYLAR, Kerendia, MOUNJARO, INSPIRE.
Industry payments across TX — which companies pay providers there.
